Menu Back toV6-S3

14th DIA Japan Annual Meeting 2017

[V6-S3] The Way toward Commercialization, Regenerative Medical Products

    Session Chair(s)
      Yoji  Sato, PhD

      Yoji Sato, PhD

      • Head, Division of Cell-Based Therapeutic Products
      • National Institute of Health Sciences, Japan
    The long way is lying from the discovery of regenerative medical seeds toward the commercialization. In this session, hot topics in academia study and current development case in company will be presented. And also, the considering points in clinical trial of approved regenerative medical products from reviewer point of view will be explained. The issues emerging in the various development stages will be identified and the solutions will be explored through the lectures and panel discussion.
      Ichiro  Sekiya, MD, PhD

      Challenge from Academia to Remove Knee Pain by Regenerative Medicine

      Ichiro Sekiya, MD, PhD

      • Professor
      • Tokyo Medical and Dental University, Japan
      Setsuko  Hashimoto, PhD

      Developing Regenerative Medicine using Cell Sheet Engineering

      Setsuko Hashimoto, PhD

      • President and CEO
      • CellSeed Inc., Japan
      Yoshiaki  Maruyama, PhD

      Safety and Efficacy Evaluation of Regenerative Medical Products

      Yoshiaki Maruyama, PhD

      • Review Director, Office of Cellular and Tissue-based Products
      • Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Contact us

Please contact the DIA Japan office in Tokyo for further information.

Tel: +81-3-6214-0574
Fax: +81-3-3278-1313